Back to Agenda
Research in Participants with Progressive Cognitive Impairment: Best Practices for Ensuring Continuing Informed Consent
Session Chair(s)
Karla Childers, MS
Vice President, Bioethics, Policy & Partnerships
Johnson & Johnson, United States
The session will describe informed consent in research participants with cognitive decline, discussing behavioral cues and consent/assent requirements for ethical practices when participants lose the ability to provide informed consent during a study
Learning Objective : Recognize the ethical and operational challenges of engaging participants with cognitive impairment; Describe ethical options for retaining participants with cognitive impairment in clinical trials; Review best practices for informed consent/ caregiver consent/participant assent when the ability to give consent is lost during the course of a trial
Speaker(s)
Sharing Clinical/Investigator Perspective
Thos Cochrane, MD, MBA
Harvard Medical School, United States
Director, Fellowships in Bioethics
Sharing an IRB Perspective
Linda Reuter, MS
BRANY IRB, United States
Senior Director
Have an account?